EMEA (Europe, Middle East and Africa) Drugs for Malaria Market Report 2017

December 2017 | 107 pages | ID: E0F09BA2E3FEN
QYResearch

Abstracts

In this report, the EMEA Drugs for Malaria market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Drugs for Malaria for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Drugs for Malaria market competition by top manufacturers/players, with Drugs for Malaria sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Cipla
• Guilin Pharmaceutical
• IPCA Laboratories
• GlaxoSmithKline
• Mylan Labs
• Roche
• Novartis
• Sanofi Aventis
• Ajanta Pharma

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Aryl Aminoalcohol Compounds
• Antifolate Compounds
• Artemisinin Compounds

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Prevention
• Treatment
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Drugs for Malaria Market Report 2017

1 DRUGS FOR MALARIA OVERVIEW

1.1 Product Overview and Scope of Drugs for Malaria
1.2 Classification of Drugs for Malaria
  1.2.1 EMEA Drugs for Malaria Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Drugs for Malaria Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Aryl Aminoalcohol Compounds
  1.2.4 Antifolate Compounds
  1.2.5 Artemisinin Compounds
1.3 EMEA Drugs for Malaria Market by Application/End Users
  1.3.1 EMEA Drugs for Malaria Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Prevention
  1.3.3 Treatment
  1.3.4 Other
1.4 EMEA Drugs for Malaria Market by Region
  1.4.1 EMEA Drugs for Malaria Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Drugs for Malaria (2012-2022)
  1.5.1 EMEA Drugs for Malaria Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Drugs for Malaria Revenue and Growth Rate (2012-2022)

2 EMEA DRUGS FOR MALARIA COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Drugs for Malaria Market Competition by Players/Manufacturers
  2.1.1 EMEA Drugs for Malaria Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Drugs for Malaria Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Drugs for Malaria Sale Price by Players (2012-2017)
2.2 EMEA Drugs for Malaria (Volume and Value) by Type/Product Category
  2.2.1 EMEA Drugs for Malaria Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Drugs for Malaria Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Drugs for Malaria Sale Price by Type (2012-2017)
2.3 EMEA Drugs for Malaria (Volume) by Application
2.4 EMEA Drugs for Malaria (Volume and Value) by Region
  2.4.1 EMEA Drugs for Malaria Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Drugs for Malaria Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Drugs for Malaria Sales Price by Region (2012-2017)

3 EUROPE DRUGS FOR MALARIA (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Drugs for Malaria Sales and Value (2012-2017)
  3.1.1 Europe Drugs for Malaria Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Drugs for Malaria Revenue and Growth Rate (2012-2017)
3.2 Europe Drugs for Malaria Sales and Market Share by Type
3.3 Europe Drugs for Malaria Sales and Market Share by Application
3.4 Europe Drugs for Malaria Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Drugs for Malaria Sales Volume by Countries (2012-2017)
  3.4.2 Europe Drugs for Malaria Revenue by Countries (2012-2017)
  3.4.3 Germany Drugs for Malaria Sales and Growth Rate (2012-2017)
  3.4.4 France Drugs for Malaria Sales and Growth Rate (2012-2017)
  3.4.5 UK Drugs for Malaria Sales and Growth Rate (2012-2017)
  3.4.6 Russia Drugs for Malaria Sales and Growth Rate (2012-2017)
  3.4.7 Italy Drugs for Malaria Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Drugs for Malaria Sales and Growth Rate (2012-2017)

4 MIDDLE EAST DRUGS FOR MALARIA (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Drugs for Malaria Sales and Value (2012-2017)
  4.1.1 Middle East Drugs for Malaria Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Drugs for Malaria Revenue and Growth Rate (2012-2017)
4.2 Middle East Drugs for Malaria Sales and Market Share by Type
4.3 Middle East Drugs for Malaria Sales and Market Share by Application
4.4 Middle East Drugs for Malaria Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Drugs for Malaria Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Drugs for Malaria Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Drugs for Malaria Sales and Growth Rate (2012-2017)
  4.4.4 Israel Drugs for Malaria Sales and Growth Rate (2012-2017)
  4.4.5 UAE Drugs for Malaria Sales and Growth Rate (2012-2017)
  4.4.6 Iran Drugs for Malaria Sales and Growth Rate (2012-2017)

5 AFRICA DRUGS FOR MALARIA (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Drugs for Malaria Sales and Value (2012-2017)
  5.1.1 Africa Drugs for Malaria Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Drugs for Malaria Revenue and Growth Rate (2012-2017)
5.2 Africa Drugs for Malaria Sales and Market Share by Type
5.3 Africa Drugs for Malaria Sales and Market Share by Application
5.4 Africa Drugs for Malaria Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Drugs for Malaria Sales Volume by Countries (2012-2017)
  5.4.2 Africa Drugs for Malaria Revenue by Countries (2012-2017)
  5.4.3 South Africa Drugs for Malaria Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Drugs for Malaria Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Drugs for Malaria Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Drugs for Malaria Sales and Growth Rate (2012-2017)

6 EMEA DRUGS FOR MALARIA MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Cipla
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Drugs for Malaria Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Cipla Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Guilin Pharmaceutical
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Drugs for Malaria Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Guilin Pharmaceutical Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 IPCA Laboratories
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Drugs for Malaria Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 IPCA Laboratories Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 GlaxoSmithKline
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Drugs for Malaria Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 GlaxoSmithKline Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Mylan Labs
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Drugs for Malaria Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Mylan Labs Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Roche
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Drugs for Malaria Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Roche Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Novartis
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Drugs for Malaria Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Novartis Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Sanofi Aventis
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Drugs for Malaria Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Sanofi Aventis Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Ajanta Pharma
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Drugs for Malaria Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Ajanta Pharma Drugs for Malaria Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview

7 DRUGS FOR MALARIA MANUFACTURING COST ANALYSIS

7.1 Drugs for Malaria Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Drugs for Malaria

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Drugs for Malaria Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Drugs for Malaria Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA DRUGS FOR MALARIA MARKET FORECAST (2017-2022)

11.1 EMEA Drugs for Malaria Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Drugs for Malaria Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Drugs for Malaria Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Drugs for Malaria Price and Trend Forecast (2017-2022)
11.2 EMEA Drugs for Malaria Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Drugs for Malaria Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Drugs for Malaria Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Drugs for Malaria Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Drugs for Malaria Sales Forecast by Type (2017-2022)
11.7 EMEA Drugs for Malaria Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Drugs for Malaria
Figure EMEA Drugs for Malaria Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Drugs for Malaria Sales Volume Market Share by Type (Product Category) in 2016
Figure Aryl Aminoalcohol Compounds Product Picture
Figure Antifolate Compounds Product Picture
Figure Artemisinin Compounds Product Picture
Figure EMEA Drugs for Malaria Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Drugs for Malaria by Application in 2016
Figure Prevention Examples
Table Key Downstream Customer in Prevention
Figure Treatment Examples
Table Key Downstream Customer in Treatment
Figure Other Examples
Table Key Downstream Customer in Other
Figure EMEA Drugs for Malaria Market Size (Million USD) by Region (2012-2022)
Figure Europe Drugs for Malaria Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Drugs for Malaria Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Drugs for Malaria Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Drugs for Malaria Revenue (Million USD) Status and Forecast by Countries
Figure Africa Drugs for Malaria Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Drugs for Malaria Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Drugs for Malaria Sales Volume and Growth Rate (2012-2022)
Figure EMEA Drugs for Malaria Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Drugs for Malaria Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Drugs for Malaria Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Drugs for Malaria Sales Share by Players (2012-2017)
Figure 2016 Drugs for Malaria Sales Share by Players
Figure 2017 Drugs for Malaria Sales Share by Players
Figure EMEA Drugs for Malaria Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Drugs for Malaria Revenue (Million USD) by Players (2012-2017)
Table EMEA Drugs for Malaria Revenue Share by Players (2012-2017)
Table 2016 EMEA Drugs for Malaria Revenue Share by Players
Table 2017 EMEA Drugs for Malaria Revenue Share by Players
Table EMEA Drugs for Malaria Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Drugs for Malaria Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Drugs for Malaria Sales Share by Type (2012-2017)
Figure Sales Market Share of Drugs for Malaria by Type (2012-2017)
Figure EMEA Drugs for Malaria Sales Market Share by Type (2012-2017)
Table EMEA Drugs for Malaria Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Drugs for Malaria Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Drugs for Malaria by Type in 2016
Table EMEA Drugs for Malaria Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Drugs for Malaria Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Drugs for Malaria Sales Share by Application (2012-2017)
Figure Sales Market Share of Drugs for Malaria by Application (2012-2017)
Figure EMEA Drugs for Malaria Sales Market Share by Application in 2016
Table EMEA Drugs for Malaria Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Drugs for Malaria Sales Share by Region (2012-2017)
Figure Sales Market Share of Drugs for Malaria by Region (2012-2017)
Figure EMEA Drugs for Malaria Sales Market Share in 2016
Table EMEA Drugs for Malaria Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Drugs for Malaria Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Drugs for Malaria by Region (2012-2017)
Figure EMEA Drugs for Malaria Revenue Market Share Regions in 2016
Table EMEA Drugs for Malaria Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Drugs for Malaria Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Drugs for Malaria Revenue and Growth Rate (2012-2017)
Table Europe Drugs for Malaria Sales (K Units) by Type (2012-2017)
Table Europe Drugs for Malaria Market Share by Type (2012-2017)
Figure Europe Drugs for Malaria Market Share by Type in 2016
Table Europe Drugs for Malaria Sales (K Units) by Application (2012-2017)
Table Europe Drugs for Malaria Market Share by Application (2012-2017)
Figure Europe Drugs for Malaria Market Share by Application in 2016
Table Europe Drugs for Malaria Sales (K Units) by Countries (2012-2017)
Table Europe Drugs for Malaria Sales Market Share by Countries (2012-2017)
Figure Europe Drugs for Malaria Sales Market Share by Countries (2012-2017)
Figure Europe Drugs for Malaria Sales Market Share by Countries in 2016
Table Europe Drugs for Malaria Revenue (Million USD) by Countries (2012-2017)
Table Europe Drugs for Malaria Revenue Market Share by Countries (2012-2017)
Figure Europe Drugs for Malaria Revenue Market Share by Countries (2012-2017)
Figure Europe Drugs for Malaria Revenue Market Share by Countries in 2016
Figure Germany Drugs for Malaria Sales (K Units) and Growth Rate (2012-2017)
Figure France Drugs for Malaria Sales (K Units) and Growth Rate (2012-2017)
Figure UK Drugs for Malaria Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Drugs for Malaria Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Drugs for Malaria Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Drugs for Malaria Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Drugs for Malaria Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Drugs for Malaria Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Drugs for Malaria Sales (K Units) by Type (2012-2017)
Table Middle East Drugs for Malaria Market Share by Type (2012-2017)
Figure Middle East Drugs for Malaria Market Share by Type (2012-2017)
Table Middle East Drugs for Malaria Sales (K Units) by Applications (2012-2017)
Table Middle East Drugs for Malaria Market Share by Applications (2012-2017)
Figure Middle East Drugs for Malaria Sales Market Share by Application in 2016
Table Middle East Drugs for Malaria Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Drugs for Malaria Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Drugs for Malaria Sales Volume Market Share by Countries in 2016
Table Middle East Drugs for Malaria Revenue (Million USD) by Countries (2012-2017)
Table Middle East Drugs for Malaria Revenue Market Share by Countries (2012-2017)
Figure Middle East Drugs for Malaria Revenue Market Share by Countries (2012-2017)
Figure Middle East Drugs for Malaria Revenue Market Share by Countries in 2016
Figure Saudi Arabia Drugs for Malaria Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Drugs for Malaria Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Drugs for Malaria Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Drugs for Malaria Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Drugs for Malaria Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Drugs for Malaria Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Drugs for Malaria Sales (K Units) by Type (2012-2017)
Table Africa Drugs for Malaria Sales Market Share by Type (2012-2017)
Figure Africa Drugs for Malaria Sales Market Share by Type (2012-2017)
Figure Africa Drugs for Malaria Sales Market Share by Type in 2016
Table Africa Drugs for Malaria Sales (K Units) by Application (2012-2017)
Table Africa Drugs for Malaria Sales Market Share by Application (2012-2017)
Figure Africa Drugs for Malaria Sales Market Share by Application (2012-2017)
Table Africa Drugs for Malaria Sales Volume (K Units) by Countries (2012-2017)
Table Africa Drugs for Malaria Sales Market Share by Countries (2012-2017)
Figure Africa Drugs for Malaria Sales Market Share by Countries (2012-2017)
Figure Africa Drugs for Malaria Sales Market Share by Countries in 2016
Table Africa Drugs for Malaria Revenue (Million USD) by Countries (2012-2017)
Table Africa Drugs for Malaria Revenue Market Share by Countries (2012-2017)
Figure Africa Drugs for Malaria Revenue Market Share by Countries (2012-2017)
Figure Africa Drugs for Malaria Revenue Market Share by Countries in 2016
Figure South Africa Drugs for Malaria Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Drugs for Malaria Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Drugs for Malaria Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Drugs for Malaria Sales (K Units) and Growth Rate (2012-2017)
Table Cipla Drugs for Malaria Basic Information List
Table Cipla Drugs for Malaria Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Cipla Drugs for Malaria Sales (K Units) and Growth Rate (2012-2017)
Figure Cipla Drugs for Malaria Sales Market Share in EMEA (2012-2017)
Figure Cipla Drugs for Malaria Revenue Market Share in EMEA (2012-2017)
Table Guilin Pharmaceutical Drugs for Malaria Basic Information List
Table Guilin Pharmaceutical Drugs for Malaria Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Guilin Pharmaceutical Drugs for Malaria Sales (K Units) and Growth Rate (2012-2017)
Figure Guilin Pharmaceutical Drugs for Malaria Sales Market Share in EMEA (2012-2017)
Figure Guilin Pharmaceutical Drugs for Malaria Revenue Market Share in EMEA (2012-2017)
Table IPCA Laboratories Drugs for Malaria Basic Information List
Table IPCA Laboratories Drugs for Malaria Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure IPCA Laboratories Drugs for Malaria Sales (K Units) and Growth Rate (2012-2017)
Figure IPCA Laboratories Drugs for Malaria Sales Market Share in EMEA (2012-2017)
Figure IPCA Laboratories Drugs for Malaria Revenue Market Share in EMEA (2012-2017)
Table GlaxoSmithKline Drugs for Malaria Basic Information List
Table GlaxoSmithKline Drugs for Malaria Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Drugs for Malaria Sales (K Units) and Growth Rate (2012-2017)
Figure GlaxoSmithKline Drugs for Malaria Sales Market Share in EMEA (2012-2017)
Figure GlaxoSmithKline Drugs for Malaria Revenue Market Share in EMEA (2012-2017)
Table Mylan Labs Drugs for Malaria Basic Information List
Table Mylan Labs Drugs for Malaria Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Mylan Labs Drugs for Malaria Sales (K Units) and Growth Rate (2012-2017)
Figure Mylan Labs Drugs for Malaria Sales Market Share in EMEA (2012-2017)
Figure Mylan Labs Drugs for Malaria Revenue Market Share in EMEA (2012-2017)
Table Roche Drugs for Malaria Basic Information List
Table Roche Drugs for Malaria Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Roche Drugs for Malaria Sales (K Units) and Growth Rate (2012-2017)
Figure Roche Drugs for Malaria Sales Market Share in EMEA (2012-2017)
Figure Roche Drugs for Malaria Revenue Market Share in EMEA (2012-2017)
Table Novartis Drugs for Malaria Basic Information List
Table Novartis Drugs for Malaria Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis Drugs for Malaria Sales (K Units) and Growth Rate (2012-2017)
Figure Novartis Drugs for Malaria Sales Market Share in EMEA (2012-2017)
Figure Novartis Drugs for Malaria Revenue Market Share in EMEA (2012-2017)
Table Sanofi Aventis Drugs for Malaria Basic Information List
Table Sanofi Aventis Drugs for Malaria Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Sanofi Aventis Drugs for Malaria Sales (K Units) and Growth Rate (2012-2017)
Figure Sanofi Aventis Drugs for Malaria Sales Market Share in EMEA (2012-2017)
Figure Sanofi Aventis Drugs for Malaria Revenue Market Share in EMEA (2012-2017)
Table Ajanta Pharma Drugs for Malaria Basic Information List
Table Ajanta Pharma Drugs for Malaria Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Ajanta Pharma Drugs for Malaria Sales (K Units) and Growth Rate (2012-2017)
Figure Ajanta Pharma Drugs for Malaria Sales Market Share in EMEA (2012-2017)
Figure Ajanta Pharma Drugs for Malaria Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Drugs for Malaria
Figure Manufacturing Process Analysis of Drugs for Malaria
Figure Drugs for Malaria Industrial Chain Analysis
Table Raw Materials Sources of Drugs for Malaria Major Manufacturers in 2016
Table Major Buyers of Drugs for Malaria
Table Distributors/Traders List
Figure EMEA Drugs for Malaria Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Drugs for Malaria Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Drugs for Malaria Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Drugs for Malaria Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Drugs for Malaria Sales Market Share Forecast by Region (2017-2022)
Table EMEA Drugs for Malaria Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Drugs for Malaria Revenue Market Share Forecast by Region (2017-2022)
Table Europe Drugs for Malaria Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Drugs for Malaria Sales Market Share Forecast by Countries (2017-2022)
Table Europe Drugs for Malaria Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Drugs for Malaria Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Drugs for Malaria Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Drugs for Malaria Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Drugs for Malaria Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Drugs for Malaria Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Drugs for Malaria Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Drugs for Malaria Sales Market Share Forecast by Countries (2017-2022)
Table Africa Drugs for Malaria Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Drugs for Malaria Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Drugs for Malaria Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Drugs for Malaria Sales Market Share Forecast by Type (2017-2022)
Table EMEA Drugs for Malaria Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Drugs for Malaria Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources